Skip to main content

What the FDA labels say about taking them together

Efavirenz and sirolimus

Efavirenz's FDA label of March 31, 2024 names sirolimus in its drug interactions section; the sirolimus labels PlainMeds reads (4) do not name efavirenz. The efavirenz label: “Dose adjustments of the immunosuppressant may be required. Close monitoring of immunosuppressant concentrations for at least 2 weeks is recommended when starting or stopping treatment with efavirenz.”

Check it at the source: the efavirenz FDA label on DailyMed (effective March 31, 2024, Cipla USA Inc.); the sirolimus FDA label on DailyMed (effective January 28, 2026, Glenmark Pharmaceuticals Inc., USA).

What does the efavirenz label say about sirolimus?

Efavirenz label, drug interactions

Concomitant Drug Class/Drug Name: Immunosuppressants: Cyclosporine, tacrolimus, sirolimus and others metabolized by CYP3A; Effect: ↓ immunosuppressant; Clinical Comment: Dose adjustments of the immunosuppressant may be required. Close monitoring of immunosuppressant concentrations for at least 2 weeks (until stable concentrations are reached) is recommended when starting or stopping treatment with efavirenz.

Source: FDA drug label (Efavirenz), Cipla USA Inc., effective March 31, 2024 (SPL set 92603fa5-7a2c-4bfb-9a70-aadb4fba952c), via openFDA; the full label on DailyMed

What does the sirolimus label say about efavirenz?

Sirolimus's label (effective January 28, 2026) and its 3 other brand-application labels do not name efavirenz in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (sirolimus), Glenmark Pharmaceuticals Inc., USA, effective January 28, 2026 (SPL set 57fb4d90-3ccb-4a69-af1e-53be83f7a504), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Efavirenz generic labelers
17Sirolimus generic labelers
EfavirenzSirolimus
Labeled forHIVOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$1.28 per tablet 600 mg tablet$0.723 per tablet 1 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?